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Summary.-I.p. immunization with y-irradiated hepatoma cells induces resistance
to s.c. tumour-cell challenge in syngeneic WAB/Not rats. Mild heat treatment ofthese
cells (>410C for 30 min) destroyed this immunoprotective effect, but did not abolish
tumour-specific antibody production in treated rats. The binding of syngeneic and
alloantibodies to surface antigens expressed on hepatoma cells was unaffected by
heat treatment. Thus, heat-treated y-irradiated hepatoma cells retain a serologically
defined tumour-specific antigen but are unable to elicit immunoprotection. By
examining the incorporation of radioactive precursors into DNA, RNA and protein
in heat-treated cells, it was determined that above 41°C there was a significant
decrease in metabolic activity. It is postulated that for the effective induction of
transplantation immunity to tumours, tumour-specific antigens should be present
on the surface membranes of a metabolically active cell. This hypothesis accounts for
the absence or marked reduction of immunoprotection induced by inviable or
glutaraldehyde-treated cells, isolated cell membranes and soluble tumour extracts
which retain serologically defined tumour-specific antigens.
THE aminoazodye-induced rathepatoma
D23 is characterized by the expression of
a tumour-specific antigen against which it
is possible to induce significant immuno-
protection by pre-treatment with y-
irradiated tumour cells. However, sub-
cellular fractions, including plasma mem-
branes and solubilized antigen prepara-
tions, are markedly ineffective in inducing
resistance to tumour-cell challenge (Price
& Baldwin, 1974; Price et al., 1978) even
though these preparations retain sero-
logically defined tumour-specific antigen
and may elicit specific antibody produc-
tion. Clearly then, there is a major
difference between tumour-specific anti-
gens expressed on an intact cell membrane
of an attenuated cell and antigens present
in cell-free extracts.
There is evidence that for the induction
of a primary lymphoid cell-mediated
immune response in vitro, active metabo-
lism of the stimulating cells is required
(Wagner, 1973; Wagner et al., 1973;
Davidson, 1977). Extracts of stimulating
cells, including plasma membranes, or
inviable and metabolically inhibited cells,
were found to be generally ineffective in
generating a primary proliferative or cyto-
toxic response. There is thus a parallel
between the inability of extracts of
stimulating cells to generate an allogeneic
cell-mediated immune response in vitro
and the inability of acellular tumour-
antigen preparations to immunize syn-
geneic rats.
As part of our attempt to elucidate the
underlying mechanisms by which y-
irradiated hepatoma cells provide im-
munoprotection, whereas acellular anti-
gens are comparatively lacking in this
property, we have modified these cells by
various procedures. In the accompanying
report (Price et al., 1979) it was deter-
mined that glutaraldehyde stabilization of
hepatoma D23 cell surfaces abolished
their immunogenicity, even though sero-
logically defined tumour-specific antigensHEAT TREATMENT OF RAT HEPATOMA CELLS
were still demonstrable. In this com-
munication we describe the results of
experiments using y-irradiated hepatoma
D23 cells held at elevated temperatures
for 30 min, and attempt to correlate the
immunogenicity of these heated cells with
their retention of biosynthetic activity.
MATERIALS AND METHODS
Animals, tumours, 8era, irradiation of
tumour cells and membrane immunofluorecence
assays-.Details of the induction and main-
tenance of tumours in syngeneic WAB/Not
rats, the preparation and collection of sera,
y-irradiation of tumour cells and antibody
assays are given in the accompanying report
(Price et al., 1979).
Immunization with heated, y-irradiated
hepatoma cells.-Single-cell suspensions of
y-irradiated hepatoma D23 cells (3 x 107
cells/ml in Hanks' balanced salt solution,
HBSS) were incubated for 30 min at various
temperatures. The cells were sedimented at
30 g for 5 min and resuspended to the
original volume in ice-cold HBSS. WAB/Not
rats were immunized with a single i.p. injec-
tion of 3 x 107 treated or untreated y-irradi-
ated D23 cells suspended in HBSS, and an
s.c. challenge of 103 viable D23 cells was
inoculated 7 days later.
Radiochemicals.-[Methyl-3H] thymidine
(20 Ci/mmol), [5-3H] uridine (28 Ci/mmol) and
L-[4,5-3H] leucine (58 Ci/mmol) were ob-
tained from the Radiochemical Centre,
Amersham, England.
Measurement of the metabolic activity of
hepatoma D23 cells.-D23 cells (pre-treated
as described in Results) were incubated in
Eagle's medium plus 10% heat-inactivated
calf serum in flat-bottom microtest plates
(Cooke M29ARTL Microtitre plates) at a con-
centration of 3 x 105 cells per well, in an
atmosphere of C02/air (5% v/v) at 37°C with
0-3 ,uCi of 3H-leucine, 3H-uridine or 3H-
thymidine, in a total volume of 0-23 ml per
well. After incubation for 24 h, the plates
were centrifuged at 280 g for 10 min and the
supernatants were removed by gentle
aspiration. Cells were lysed by the addition of
0 1 ml Decon (1:20, v/v) to each well. After
10 min, Olml aliquots of 10% (w/v) tri-
chloroacetic acid (TCA) were added to each
well and, after a further 10 min, TCA-
insoluble material was collected and washed
on paper discs using a Dynatech Automash
cell harvester. Discs were dried and counted
in a Packard Tri-Carb Model 3390 Liquid
Scintillation Spectrometer.
RESULTS
Hepatoma D23 cells subjected to 15,000
rad y-irradiation exhibited reduced meta-
bolic activity, as measured by the incor-
poration of 3H-leucine, 3H-thymidine and
3H-uridine (Table I). The largest reduction
in incorporation was seen with 3H-
thymidine, which is consistent with radi-
ation damage to DNA. 3H-uridine incor-
poration into RNA was reduced to 57%,
and 3H-leucine incorporation into protein
was reduced to 41% of the values for un-
irradiated D23 cells. Thus, whilst y-
irradiated D23 cells appear "viable" by
vital-dye-exclusion criteria (>95% ofcells
excluded Trypan blue in all samples), they
retain a residual metabolic activity, at
least during the 24h period in which
isotope uptake was measured (Table I).
TABLE I.-Effect of y-irradiation (15,000
rad) upon the incorporation of radio-
isotopically-labelled precursors into D23
cells
Precursor
3H-Thymidine
3H-Uridine
3H-Leucine
Incorporation
(mean ct/min+ s.e., x 10-4/24 h)
Unirradiated Irradiated
cells cells
7-67+0-78 1-14±0-10
0-63±0-12 0-36+0-04
1-38±0-18 0-56±0-06
To evaluate whether the retention of a
residual metabolic activity in y-irradiated
cells was associated with their immuno-
genic capacity, these cells were incubated
at various elevated temperatures for 30
min. It was determined that when heat-
treated, y-irradiated cells were incubated
with 3H-leucine, 3H-thymidine and 3H-
uridine, there was a significant decrease in
the incorporation of labelled precursors in
samples held at temperatures above 41°C
(Fig. 1). Table II shows the results of 3
separate experiments in which the im-
munogenicity of heat-treated, y-irradiated
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activation of surface antioens. heated cells CA% UXV V IL ".J " 4 X ,_, CA,- t, "- l-
were employed as targets in indirect
membrane-immunofluorescence assays.
Two types of syngeneic sera from rats
immunized with y-irradiated D23 grafts
or bearing i.p. implants of D23 were used,
since these have been shown to be reactive
with the individually distinct tumour-
specific antigen expressed upon D23
(Baldwin & Barker, 1967; Price & Bald-
win, 1977). Also, the reactivity of a KX/
Not anti-WAB/Not serum for alloantigens
37 39 41 43 4'5 associated with D23 was tested using
Temp 4C heated target cells. As shown in Table III,
ncorporatioin after 24 h of 3H- there was no significant difference in
(0), 3H-thymidine (0) ancl 3H- fluorescence indices between cells held at
(A) into y-irradliated D23 cells 00C, 37°C and 450C, using either syngeneic
1-inctubation for :30 mi at variouss . ' '
tures. Bais indlicate standard error. immune sera or the KX/Not anti-WAB/
Not antiseruim, indicating that both
was examined. In these tests, tumour-specific and alloantigenic deter-
d at above 41°C were essentially minants were not heat-labile at tempera-
tive, and immunized rats failed tures up to 45°C.
in s.e. challenge of 103 viable That tumour-specific antigens asso-
lls, whereas rats treated with ciated with D23 were not heat-labile at
at 370C were largely protected temperatures up to 450C was confirmed by
Lllenge (Table II). a further experiment, the results of which
r to determine whether the are given in Table IV. Two groups of 3
)ss ofimmunogenicity of mildly WrAB/Not rats were immunized x4 at
Is was associated with any in- weekly intervals with y-irradiated hepat-
TABLE II. Imrmunization with heat-treated, y-irradiated D23 cells
PIretreatment
No. of of immuilizing Tuimnou inMcidence* inI:
iunmunllizing cells
cells for :30 min Expt. 1 Expt. 2 Expt. :3 Total (0)
0 5/6 6/6 5/6 16/18 (89)
3x 1(7 37 C: 0/6 3/t6 0/6 3/18 (17)
3 x 1(07 39 C: NTt 3/6 NT 3/6 (50)
3 x 107 41°C: NT 2/6 4/6 6/12 (50)
3 x 107 43C: NT 6/6 5/6 11/12 (92)
3 x 107 45°C: 6/6 5/6 4/6 15/18 (83)
3 X 107 47C: NT NT 5/6 5/6 (83)
* All rats werIe challenged by s.c. injectioln of 103 viable ttumotur cells 7 (lays after i.). inuiiiztion.
t NT Not tested(.
TABLE III. Men-m,brane-irm2mrtunoflitorescence reactions with heat-treated, y-irradiated
D23 cells
Serulmll
D23 IR graft-immuniie seruim
D23 Tumour-bearer serum
KX/Not anti-WAB/Not alloantiserum
Flutorescerice in(lices (mean-s.e.) against
D23 cells heate(d for 30 mjii at:
(OC 37°C 45°C
0-62 0 04 0 69 0 06 0-58 00:3
0-58A 006 0(59±0 06 0 48 007
1.00oo2 0o00 1*00X4-0-00 1 0oo o-oo
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TABLE IV.-Humoral response to immu-
nization with heat-treated, y-irradiated
D23 cells
Fluorescence indices
(meani±s.e.) against:
Immunization ,
procedure* D23 cells
107 y-irradiated
D23 cells at 37°C 0 43±0 07
107 y-irradiated
D23 cells at 45°C 0-42±0-10
* All rats were immunized by 4 i
cells as described.
omas preheated to either 3704
the sera were tested against
target cells, using the indirec
immunofluorescence assay.
Table IV, syngeneic antibo
with D23 cells but not MT
demonstrable in sera from ra
with y-irradiated D23 cells
at both 37°C and 450C.
Finally, since the results
munication indicate that t
genicity of y-irradiated D23
viable cell challenge is associ,
retention of residual metab
and since the previous re
strated that immunogenici
labile to glutaraldehyde trea
et al., 1979), the effects of gl
upon the metabolic activity o
cells was examined. As shov
x
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FIG. 2. Incorporation after 24
leucine and 3H-thymidine into
hyde-treated D23 cells. Bar
standard error.
glutaraldehyde treatment at concentra-
tions of 0-01% and 0-5% almost totally
abolished the cells' biosynthetic activity.
DISCUSSION
The results presented in this report D30 cells indicate that heating radiation-attenuated
0 06±0 03 D23 cells above 41°C for 30 min markedly
reduces their capacity to immunize syn-
0 04±0 05 geneic rats against a subsequent viable
i.p. injections of tumour-cell challenge. However, tumour-
specific antigens are still serologically
demonstrable on these cells, and their
C or 45°C and ability to induce antibody production in
D23 and D30 treated WAB/Not rats is not impaired.
-t membrane- The loss of immunogenicity after mild
As shown in heat treatment is paralleled by a reduction
dies reactive in biosynthetic capacity as measured by
30 cells were the incorporation of labelled precursors
ts immunized into DNA, RNA and protein. Thus
re-incubated tumour immunogenicity correlating with
active cell metabolism is related to the loss
of this com- of immunizing potential of isolated cell
the immuno- membranes and solubilized membrane
cells against extracts of D23 (Price & Baldwin, 1974;
ated with the Price et al., 1978). The presence of a
tolic activity, tumour-specific antigen alone may fre-
port demon- quently elicitspecific antibodyproduction,
ty was also and the expression of this determinant is
ttment (Price also a necessary, but not sufficient con-
utaraldehyde dition for the induction of an accompany-
ify-irradiated ing effective tumour-rejection response
wn in Fig. 2, against D23. This concl-usion cannot be
generally applied directly to the immuno-
genic capacity of cellular antigen prepara-
tions or chemically inactivated (e.g. iodo-
acetamide-treated) tumours in the mouse,
Thymidine rat or guinea-pig, since in several in- stances immunoprotection may be afford-
ed using such materials (reviewed by
Law & Appella, 1975; Baldwin & Price,
1975). However, resistance to tumour cell
challenge has usually been revealed after
multiple injections oftumour antigen and/
or using very large doses of immunogen
OEn Q; compared to the minimum number of 0.04 Q5 radiation-attenuated tumour cells that
would be necessary to induce an equal
h of 3H- rejection response (e.g. with the moder-
glutaralde- ately immunogenic tumour, D23, 3 injec- rs indicate i ognl i
tions of only 105 irradiated cells are
r
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sufficient to demonstrate transplantation
immunity, whereas, using soluble antigens,
only weak retardation of tumour growth
was evident in rats immunized with
milligram quantities of immunogen-
Price et al., 1978). Thus, it is reasonable to
conclude that although retention of
tumour-specific antigen in the immunogen
is a necessary condition to elicit specific
tumour-transplantation immunity, it is
insufficient for the induction of an effec-
tive, or optimal, rejection response against
antigenic tumours.
The studies in this and the accompany-
ing report (Price et al., 1979) therefore
indicate that the mode of presentation of
tumour antigens to the immune apparatus
of the recipient is of critical importance,
and that immunogenicity is labile to even
mild heat treatment. One explanation for
this is that the treatments adopted have
modified the survival of the inoculated
cells and hence altered the degree of anti-
genie stimulation. However, as shown in
Table IV, heat-treated cells are at least
able to induce tumour-specific antibody
production in a manner comparable to
their untreated counterparts, so that this
aspect of their immunogenic character is
not impaired. An alternative hypothesis
accommodating the present findings is
that tumour-specific antigens on an atten-
uated immunizing cell must be able to
adopt certain spatial configurations within
the plane of an essentially fluid surface
membrane and/or that they must be able
to associate with other membrane macro-
molecules (e.g. histocompatibility anti-
gens) for effective recognition and pro-
cessing by the immune system, leading to
the final expression of the appropriate
effector-cell population (presumably cyto-
toxic T cells) mediating rejection. Many
cell-membrane proteins and glycoproteins
exist in specific configurations at the cell
surface, and microtubules, microfilaments
and the expenditure of metabolic energy
are necessary to maintain these con-
figurations (reviewed by Nicolson, 1976).
For example, the surface localization of
histocompatibility antigens on P815
murine mastocytoma cells, or of Ig mole-
cules on lymphocytes, is controlled by their
transmembrane association with actin, a
component of cellular microfilaments
(Koch & Smith, 1978; Flanagan & Koch,
1978). Thus, it is possible that interference
with the metabolic integrity of the cell by
mild heat treatment disrupts cytoskeletal
elements and/or membrane fluidity in such
a way as to alter tumour-specific antigen
configuration. This hypothesis is currently
being evaluated by examining the im-
munogenicity of y-irradiated hepatoma
D23 cells treated with agents which dis-
rupt cytoskeletal elements or which in-
hibit specific metabolic activities.
This study was supportecl by the Cancer Research
Campaign and by a Government Equipment Grant
obtaine(d through the Royal Society.
The authors acknowledge with thanks the skilful
technical assistance of Mrs C. Arlen and Mrs C.
Wright. Mrs M. E. Addison and the staff of the
Cancer Research Animal Unit are thanked for pro-
vision and maintenance of animals.
REFERENCES
BALIoWIN, R. W. & BARKER, C. R. (1967) Demoni-
stration of tumour-specific humoral antibody
against aminoazo dye-induced rat hepatoma.
Br. J. Cancer, 21, 793.
BALDWIN, R. W. & PRICE, Al. R. (1975) Neoantigen
expression in chemical carcinogenesis. In Cancer:
A Comprehensive Treatise. Ed. F. F. Becker,
Vol. 1. New York: Plenum Press. p. 353.
DAVIDSON, W. F. (1977) Cellular requirements foI
the indluction ofcytotoxic T cells in vitro. Imnmuniol.
Rev., 35, 263.
FLANAGAN, J. & KOCH, G. L. E. (1978) Cross linked
surface Ig attaches to actin. Nature, 273, 278.
KOCH, G. L. E. & SMITH, M. J. (1978) An association
between actin and the major histocompatibility
antigen H-2. Nature, 273, 274.
LAW, L. W. & APPELLA, E. (1975) Studies of soluble
transplantation and tumour antigens. In Cancer:
A Comprehensive Treaitise. Ed. F. F. Becker.
Vol. 4. New York: Plenum Press.
NICHOLSON, G. L. (1976) Transmembrane cointrol of
the receptors on normal and tumour cells. II.
Suirface changes associated with transformation
and malignancy. Biochem. Biophys. Acta, 458, 1.
PRICE, M. R. & BALDWIN, R. W. (1974) Immuno-
genic properties of rat hepatoma subeellular frac-
tions. Br. J. Cancer, 30, 394.
PRICE, M. R. & BALDWIN, R. W. (1977) Tumour-
specific complement-dependent serum cytotoxicity
against a chemically-induced rat hepatoma.
IJut. J. Cancer, 20, 284.
PRICE, M. R., PRESTON, V. E., ROBINS, R. A.,
ZOLLER, M. & BALDWIN, R. W. (1978) Induction of
immunity to chemically-induced rat tumours by
cellular or soluble antigens. Cancer Imrnunol.
Immunother., 3, 247.HEAT TREATMENT OF RAT HEPATOMA CELLS 635
PRICE, M. R., DENNICK, R. G., ROBINS, R. A. &
BALDWIN, R. W. (1979) Modification of the
immunogenicity and antigenicity of rat hepatoma
cells. I. Cell surface stabilization with glutaralde-
hyde. Br. J. Cancer, 39, 621.
WAGNER, H. (1973) Cell-mediated immune response
in ritro. IV. Metabolic studies on cellular immuno-
genicity. Eur. J. Immunol., 3, 84.
WAGNER, H., ROLLINGHOFF, M. & NOSSAL, G. J. V.
(1973) T-cell-mediated immune responses induced
in vitro: A probe for allograft and tumour im-
munity. Transplant. Rev., 17, 3.